Navigation Links
Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
Date:10/23/2007

C International Conference on Molecular Targets and Cancer Therapeutics in a poster titled "A Phase 2 trial of SNS-595 in women with platinum refractory epithelial ovarian cancer," Abstract No. A158.

On Wednesday, October 24, 2007 at the AACR-NCI-EORTC meeting, Sunesis will present additional non-clinical data in a poster titled "SNS-595 potentiates the in vivo activity of carboplatin, cisplatin and gemcitabine in solid tumor xenografts," Abstract No. B285. This poster presentation will take place in Poster Session B -- Other Small Molecule Therapeutics.

About SNS-595

SNS-595 is a replication-dependent DNA damaging agent that causes irreversible G2 arrest and rapid apoptosis. A secondary mechanism for SNS-595 is a unique inhibition of topoisomerase II that causes highly selective DNA damage.

Data reported today build upon positive results from non-clinical studies, and from Sunesis' dose-escalating Phase 1 clinical trial of SNS-595 in which an ovarian cancer patient with advanced disease achieved a PR. In addition to the Phase 2 clinical trial in ovarian cancer patients, SNS-595 is currently being evaluated in two Phase 1b acute leukemia clinical trials. In clinical trials conducted to date, SNS-595 has been generally well tolerated and has shown objective responses in both solid and hematological tumor types. In non-clinical evaluations, SNS-595 demonstrates broad and potent activity in xenograft, syngeneic and drug-resistant models.

About Ovarian Cancer

In the United States, ovarian cancer remains the leading cause of death from gynecologic malignancies and is the fifth leading cause of cancer death overall in women behind lung, breast, colorectal and pancreatic cancers. According to the American Cancer Society, in 2007 there will be an estimated 22,430 new cases and more than 15,000 deaths from ovarian cancer in the U.S. alone. The front-line treatment for ovarian cancer is typically a combination of a taxane and a platinum dru
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
2. Sunesis Pharmaceuticals Reports Positive Data From Studies of Two Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of the European Hematology Association
3. Sunesis Pharmaceuticals to Present Data at the 12th Congress of the European Hematology Association
4. Sunesis Presents Data Supporting SNS-032s Potential Anticancer Activity in Multiple Myeloma at the American Association for Cancer Research Meeting
5. Sunesis Pharmaceuticals to Present Data at the Annual Meeting of the American Association for Cancer Research
6. Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor Data Showing Broad Anti-Tumor Activity, Dosing Flexibility
7. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... Aug. 27, 2015  Eli Lilly and Company (NYSE: ... Healthcare Conference on Thursday, September 17, 2015. Sue ... Lilly Oncology and Richard Gaynor , M.D., senior ... Lilly Oncology, will participate in a fireside chat at ... live audio webcast will be available on the "Webcasts ...
(Date:8/27/2015)... 27, 2015   Women Grow , the fastest-growing professional networking ... with the Cannabis World Congress & Business Exposition ... 15 business-focused educational sessions. CWCBExpo in LA will take place ... Convention Center in Los Angeles, CA ... Coast for the marijuana industry. The Women Grow ...
(Date:8/27/2015)...  MiMedx Group, Inc. (NASDAQ: MDXG ), ... tissue and patent-protected processes to develop and market ... Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental ... multiple inaccuracies in the press release issued by ... rulings from the Patent Trial and Appeal Board ...
Breaking Medicine Technology:Lilly to Participate in Morgan Stanley Global Healthcare Conference 2Cannabis World Congress in Los Angeles Boasts Women Grow Sponsored Education 2Cannabis World Congress in Los Angeles Boasts Women Grow Sponsored Education 3Cannabis World Congress in Los Angeles Boasts Women Grow Sponsored Education 4MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 2MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 3MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 4
... The Consumer Healthcare Products Association (CHPA), representing ... children, applauds the U.S. Food and Drug Administration ... their children the right amount of medicine. Today, ... Advisory Committee recommended enhancing the labels of all ...
... (NYSE: LLY ) today announced that David M. ... American Diabetes Association, has been named distinguished medical fellow for ... In his new role, Kendall will serve as ... clinical science communities and as a representative to the professional ...
Cached Medicine Technology:OTC Industry Supports FDA Advisory Committee Recommendations on New Dosing Instructions 2OTC Industry Supports FDA Advisory Committee Recommendations on New Dosing Instructions 3David M. Kendall, M.D., Named Distinguished Medical Fellow at Lilly 2David M. Kendall, M.D., Named Distinguished Medical Fellow at Lilly 3
(Date:8/27/2015)... ... , ... In an article published July 30th by the New ... Orleans, highlighting a security firm that is tasked with providing supplemental protection. Called the ... worked with the city to provide private security when it is needed in a ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... one of just 20 adult-only medical centers in the United States to receive ... hearts and lungs. The Extracorporeal Life Support Organization (ELSO) , an international ...
(Date:8/27/2015)... ... 27, 2015 , ... On May 30th, 2015, at the Adams County Fairgrounds ... the “Music With A Mission” benefit concert. For the past two years, “Music With ... underfunded school districts of Mendon and neighboring town, Quincy, IL. Organized in part by ...
(Date:8/27/2015)... WILMINGTON, Del. (PRWEB) , ... August 27, 2015 , ... ... Hospital, will be the guest speaker at CURE® magazine’s 3rd Annual MPN Heroes™ ... , Dr. Arnold will be among hundreds of attendees honoring eight heroes who have ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... , scheduled for October 27-29, 2015 in San Jose, CA. The first ... primarily focus on the void that exists where battery development and energy storage ...
Breaking Medicine News(10 mins):Health News:Article on New Orleans Security Force Highlights the Abilities and Flexibility of Private Security, says Spear Security Inc. 2Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 2Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 3Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 4Health News:Best Drug Rehabilitation Interviews Madd Hoss Jackson at the 2015 "Music With A Mission" Benefit Concert 2Health News:Dr. Jennifer Arnold of ‘The Little Couple’ to Keynote 3rd Annual MPN Heroes™ Recognition Event in Orlando 2Health News:Dr. Jennifer Arnold of ‘The Little Couple’ to Keynote 3rd Annual MPN Heroes™ Recognition Event in Orlando 3Health News:Dr. Jennifer Arnold of ‘The Little Couple’ to Keynote 3rd Annual MPN Heroes™ Recognition Event in Orlando 4Health News:Infocast Hosting First Conference Dedicated to Powering Wearable Devices & the IoT 2
... NY, October 6, 2010 In recognition of the 20th ... (ADA), the October issue of Disability and Health Journal ... whether the ADA has in fact improved the health of ... acknowledging physical barriers and need for better staff training and ...
... about unethical U.S. studies on syphilis in Guatemala in the ... has written a commentary for Bioethics Forum , the ... learn from history to better protect human subjects in the ... Wellesley College, describes how she unearthed documents about the study ...
... at the Johns Hopkins Bloomberg School of Public Health ... Reviewed Orthopaedic Research Program (PRORP) of the U.S. Department ... Research Consortium (METRC). The Consortium, which was established in ... DOD, conducts multi-center studies relevant to the treatment and ...
... Reinberg HealthDay Reporter , THURSDAY, Oct. 7 (HealthDay ... illness and help prevent the spread of flu, many Americans ... this coming season, new surveys reveal. Despite the attention ... Americans say they will not be getting the vaccine this ...
... ANN ARBOR, Mich.Clinical trials in which participants are randomly ... of clinical research. When conducted correctly, it,s widely accepted ... and can be trusted. But researchers ... process for bringing therapies and medical devices to patients ...
... AURORA, Colorado (Oct. 6, 2010) The University of Colorado ... University of Colorado School of Medicine, has been awarded $6.3 ... emphasis on donors from minority groups. The three-year ... division of the United States Department of Health and Human ...
Cached Medicine News:Health News:Disability and Health Journal critically examines Americans with Disabilities Act 2Health News:Disability and Health Journal critically examines Americans with Disabilities Act 3Health News:Disability and Health Journal critically examines Americans with Disabilities Act 4Health News:Additional $38M awarded to expand orthopedic trauma care research 2Health News:Many Americans Plan to Skip Flu Shot This Year 2Health News:Many Americans Plan to Skip Flu Shot This Year 3Health News:U-M receives NIH, FDA grant to study adaptive clinical trial designs 2Health News:University of Colorado gets federal award for Cord Blood Bank 2
... and negative whole blood control to test ... solubility tests and hemoglobin electrophoresis. Sickle-Chex is ... manufacturers' solubility kits. Sickle-Chex is packaged in ... vial dispenses an accurate sample volume. No ...
... three-part differential control assayed for all parameters on ... Series, AcT/AcT diff/AcT diff2, MD Series and ONYX ... 1800; ABX Micros 60; and Diatron Abacus and ... stability of 30 days and a six-month closed-vial ...
... Cell-Chex Auto is a whole blood ... of hematology instruments that measure automated blood ... The assay provides total RBC and WBC ... and Sapphire, Beckman Coulter LH750/LH 755 (levels ...
iSleep 20i is an advanced high performance CPAP with outstanding self-adjusting i‑technology....
Medicine Products: